Aptevo Therapeutics (APVO)
(Delayed Data from NSDQ)
$0.41 USD
-0.01 (-1.56%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $0.40 -0.01 (-2.22%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -1.93 |
EPS Last Quarter | -9.95 |
Last EPS Surprise | 29.43% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -8.86 |
Next Year | -5.77 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 3.11M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.93 | -1.71 | -8.86 | -5.77 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -1.93 | -1.71 | -8.86 | -5.77 |
High Estimate | -1.93 | -1.71 | -8.86 | -5.77 |
Low Estimate | -1.93 | -1.71 | -8.86 | -5.77 |
Year ago EPS | -54.19 | -22.03 | -66.96 | -8.86 |
Year over Year Growth Est. | 96.44% | 92.24% | 86.77% | 34.88% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.93 | -1.71 | -8.86 | -5.77 |
7 Days Ago | -1.93 | -1.71 | -8.86 | -5.77 |
30 Days Ago | -1.93 | -1.71 | -8.86 | -5.77 |
60 Days Ago | -1.93 | -1.71 | -8.86 | -5.77 |
90 Days Ago | -1.89 | -1.66 | -8.85 | -5.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.93 | -1.71 | -8.86 | -5.77 |
Zacks Consensus Estimate | -1.93 | -1.71 | -8.86 | -5.77 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -9.95 | NA | -22.03 | -54.19 | NA |
Estimate | -14.10 | NA | -31.72 | -49.34 | NA |
Difference | 4.15 | NA | 9.69 | -4.85 | 3.00 |
Surprise | 29.43% | NA | 30.56% | -9.82% | 16.72% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more